Facebook Linkedin Twitter
Inside Precision Medicine MD Anderson Researchers ID CD70 as New Target in EGFR-Mutant NSCLC

Resistance mutation

MD Anderson Researchers ID CD70 as New Target in EGFR-Mutant NSCLC
News & Features

MD Anderson Researchers ID CD70 as New Target in EGFR-Mutant NSCLC

0
Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
News & Features

Biomarker Helps Identify Lymphoma Patients with Drug Resistance

0
Female doctor and bald cancer patient talking in clinic examination room
News & Features

Researchers Say They Developed an Anticancer Agent that Overcomes Drug Resistance

0
Medicines With Bottle On Purple Background
News & Features

Engineers Model Mutations that Cause Drug Resistance

0
Japanese scientists have found unique genetic alterations that could indicate whether expensive immune checkpoint inhibitors would be effective for a particular patient. Publishing in Nature
News & Features

PD-L1 Mutations ID Patients Resistant to Immunotherapy

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine